(Q34849409)

4 August 2017

title

Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer (English)

1 reference

4 August 2017

1 reference

Paul Toomey

1

1 reference

4 August 2017

Krithika Kodumudi

2

1 reference

4 August 2017

Amy Weber

3

1 reference

4 August 2017

Lisa Kuhn

4

1 reference

4 August 2017

Ellen Moore

5

1 reference

4 August 2017

Amod A Sarnaik

6

1 reference

4 August 2017

Shari Pilon-Thomas

7

1 reference

4 August 2017

language of work or name

English

0 references

publication date

17 July 2013

1 reference

4 August 2017

1 reference

4 August 2017

volume

8

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

e68561

1 reference

Creative Commons Attribution 4.0 International

4 August 2017

copyright license

start time

17 July 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Rose bengal vital staining. Staining of cornea and conjunctiva by 10 prcent rose bengal, compared with 1 percent.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Intralesional Immunotherapy of Melanoma with BCG

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Intralesional BCG in the treatment of metastatic malignant melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Immunotherapy of melanoma with BCG: Two fatalities following intralesional injection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Risks of BCG intralesional therapy: An experience with melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714270

Staining patterns in dry eye syndrome: rose bengal versus lissamine green

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068561

High response rate after intratumoral treatment with interleukin-2

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068561

Chemoablation of metastatic melanoma using intralesional Rose Bengal

21 January 2018

1 reference

12 December 2020

Immunotherapy of melanoma with intralesional BCG

1 reference

12 December 2020

Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma

1 reference

12 December 2020

Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model

1 reference

12 December 2020

Hypotension and disseminated intravascular coagulation following intralesional bacillus Calmette-Guérin therapy for locally metastatic melanoma

1 reference

12 December 2020

Anaphylactic reaction to BCG vaccination

1 reference

12 December 2020

Severe complications of intralesional BCG therapy in an unsensitized patient. Case report and clinical implications

1 reference

12 December 2020

Intralesional BCG application in malignant melanoma

1 reference

12 December 2020

BCG immunotherapy of malignant melanoma: summary of a seven-year experience

1 reference

12 December 2020

Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer

1 reference

12 December 2020

Intra-lesional interleukin-2 for the treatment of in-transit melanoma

1 reference

12 December 2020

Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma

1 reference

12 December 2020

A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0068561

Identifiers

DOI

1 reference

4 August 2017

0 references

1 reference

4 August 2017

1 reference